VC-backed Turnstone Biologics buys Myst Therapeutics

Ottawa-based biotechnology company Turnstone Biologics has acquired Myst Therapeutics, a Los Angeles-based developer of novel T-cell therapies for solid tumors.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this